Yong-Won Shin Selected Research

Yong-Won Shin Research Topics

Disease

12	Encephalitis (Encephalitis, Rasmussen) 08/2021 - 12/2013
8	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 08/2021 - 04/2014
6	Autoimmune Diseases of the Nervous System 07/2021 - 01/2016
5	Epilepsy (Aura) 01/2021 - 04/2015
4	Seizures (Absence Seizure) 07/2021 - 01/2016
3	Neoplasms (Cancer) 11/2020 - 09/2014
3	Glioma (Gliomas) 10/2018 - 12/2013
2	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 01/2019
2	Cognitive Dysfunction 01/2021 - 10/2018
2	Migraine Disorders (Migraine) 01/2019 - 09/2015
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2018 - 05/2016
1	Dyskinesias (Dyskinesia) 08/2021
1	Fever (Fevers) 07/2021
1	Inflammation (Inflammations) 07/2021
1	Exanthema (Rash) 01/2021
1	Neutropenia 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Teratoma (Teratoid Tumor) 01/2021
1	Dementia (Dementias) 11/2020
1	Intracranial Hypotension 01/2020
1	Prodromal Symptoms 11/2019
1	REM Sleep Behavior Disorder 11/2019
1	Synucleinopathies 11/2019
1	Postural Orthostatic Tachycardia Syndrome 05/2019
1	Disease Progression 01/2019
1	Hyponatremia 10/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2018
1	Persistent Vegetative State (Vegetative State) 05/2018
1	Osteoporosis 01/2018
1	Ascending Aorta Aneurysm 05/2016
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2016
1	Rupture 05/2016
1	Body Weight (Weight, Body) 04/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Ischemic Stroke 01/2016
1	Diabetes Mellitus 01/2016

Drug/Important Bio-Agent (IBA)

7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2021 - 04/2014
5	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021 - 10/2018
5	Rituximab (Mabthera)FDA Link 01/2021 - 01/2016
4	tocilizumab (atlizumab)FDA Link 07/2021 - 10/2016
4	AntibodiesIBA 01/2018 - 04/2014
3	CytokinesIBA 07/2021 - 01/2016
3	Leucine (L-Leucine)FDA Link 10/2018 - 12/2013
2	ChemokinesIBA 07/2021 - 01/2016
2	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 04/2016
2	SteroidsIBA 01/2021 - 05/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 05/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2020 - 05/2019
2	Interleukin-10 (Interleukin 10)IBA 11/2019 - 01/2016
2	Levetiracetam (Keppra)FDA LinkGeneric 10/2018 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 12/2013
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 10/2018 - 04/2016
2	AutoantibodiesIBA 02/2017 - 12/2013
1	Diazepam (Valium)FDA LinkGeneric 08/2021
1	Anesthetics (Anesthetic Agents)IBA 07/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2021
1	perampanelIBA 01/2021
1	Oligoclonal BandsIBA 01/2021
1	SirtuinsIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 11/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2020
1	B7-H1 AntigenIBA 11/2020
1	atezolizumabIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	HLA-B Antigens (HLA-B)IBA 11/2020
1	gadobutrolIBA 01/2019
1	Circular RNAIBA 01/2019
1	Proteasome InhibitorsIBA 05/2018
1	N-Methylaspartate (NMDA)IBA 05/2018
1	Bortezomib (Velcade)FDA Link 05/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	CopperIBA 05/2016
1	BilirubinIBA 04/2016
1	CreatinineIBA 04/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2016
1	AlbuminsIBA 04/2016
1	Alanine Transaminase (SGPT)IBA 04/2016
1	Phenobarbital (Luminal)FDA Link 04/2016
1	Phenytoin (Dilantin)FDA LinkGeneric 04/2016
1	Clobazam (HR 376)IBA 04/2016
1	Topiramate (Topamax)FDA LinkGeneric 04/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2016
1	Pregabalin (Lyrica)FDA Link 04/2016
1	Carbamazepine (Tegretol)FDA LinkGeneric 04/2016
1	Clonazepam (Rivotril)FDA LinkGeneric 04/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Interleukin-12 (IL 12)IBA 01/2016
1	Interleukin-13IBA 01/2016
1	Interleukin-2 (IL2)IBA 01/2016
1	fibrin fragment D (D-dimer)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Interleukin-23 (Interleukin 23)IBA 01/2016

Therapy/Procedure

8	Immunotherapy 08/2021 - 12/2013
2	Aftercare (After-Treatment) 08/2021 - 03/2021
2	Therapeutics 07/2021 - 01/2016
1	Ventriculoperitoneal Shunt 01/2020